. Author manuscript; available in PMC: 2014 Aug 2.

Published in final edited form as: J Hum Hypertens. 2013 Sep 5;28(3):157–164. doi: 10.1038/jhh.2013.81

Table 3.

Lipids

Outcomes	Median (25th–75th percentile)		Median change (95% confidence interval)		P-value
	Pre-test	Post-test	Within-group changes	Between-group changes
Cholesterol (mg dl⁻¹)				−12.5 (−23.5–5.0)	0.047 ^b
Control	163.0 (150.5–183.8)	166.0 (153.0–199.3)	13.5 (2.5–18.0)		0.07^w
RT	163.0 (140.0–176.0)	164.0 (134.0–174.0)	1.0 (−8.0–7.0)		0.53^w
HDL (mg dl⁻¹)				−1.0 (−6.0–4.0)	0.62
Control	39.0 (37.0–40.0)	41.0 (37.0–45.0)	1.0 (1.0–6.0)		0.34
RT	41.0 (39.0–45.0)	40.0 (39.0–46.0)	0.0 (−1.5–4.0)		0.53
LDL (mg dl⁻¹)				−9.5 (−27.0–4.0)	0.15
Control	102.0 (77.3–124.5)	104.5 (91.3–123.8)	7.5 (0.5–25.0)		0.07
RT	85.0 (66.0–108.0)	84.0 (72.0–101.0)	−2.0 (−12.0–10.0)		0.66
TG (mg dl⁻¹)				9.5 (−59.5–72.5)	0.98
Control	124.0 (117.8–138.5)	107.5 (99.5–115.5)	−16.5 (−55.5–94.0)		0.60
RT	118.0 (85.5–164.5)	120.0 (75.0–154.0)	−7.0 (−26.0–25.0)		0.51

Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride. Significance was calculated using the Wilcoxon signed-rank test. Pvalues with a superscript b indicate between-group analysis, and w indicates within-group analysis. Median values are presented with 25th and 75th percentile in parentheses, and median change scores are presented with the accompanied 95% confidence intervals. Significant P values (P<0.05) are bolded.